Mehrdad Malihi, MD
Retina Specialist · Portland, ORNPI 1184912925
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.8% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 41.9% of the total. That places this record below the midpoint for retina specialist clinicians in OR, where the typical reported total is $1,870.
Across 19 payments — averaging $55.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$443
- Genentech USA, Inc.$169
- Alcon$144
- Dutch Ophthalmic, USA$91
- Carl Zeiss Meditec USA, Inc.$86
- Novartis$60
- plus $65 from 3 others
What the payments were for
- Food & beverage$1,00395%
- Gifts$555%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 5 | $443 |
| Genentech USA, Inc. | 2 | $169 |
| Alcon | 1 | $144 |
| Dutch Ophthalmic, USA | 1 | $91 |
| Carl Zeiss Meditec USA, Inc. | 3 | $86 |
| Novartis | 4 | $60 |
| AbbVie | 1 | $24 |
| Astellas Pharma US Inc | 1 | $21 |
| Carl Zeiss Meditec AG | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,058 in reported general payments places this provider in the 35th percentile of 36 retina specialist providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 170 | $5,357 |
| Latanoprost | 126 | $1,489 |
| Ofloxacin | 131 | $1,433 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 34 | $417 |
| Timolol Maleate | 32 | $267 |
| ErythromycinErythromycin Base | 16 | $261 |
| Brimonidine Tartrate | 13 | $132 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Portland
- Brian Chan KaiPortland$155K
- Brandon LujanPortland$33K
- Andreas LauerPortland$17K
- Sirichai PasadhikaPortland$6K
- David WilsonPortland$5K
- Harpal SandhuPortland$3K
- Aristomenis ThanosPortland$3K
- Michael LeePortland$3K
- Paul TlucekPortland$2K
- Kavita BhavsarPortland$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.